Journal Articles

  1. & Temporal Effect of Bariatric Surgery on Predicted 10-Year and Lifetime Cardiovascular Risk at 1 Month, 6 Months, and 5 Years Following Surgery: A Pilot Study. Metabolic Syndrome and Related Disorders 15(3), 130-136.
  2. & Bariatric Surgery Is Accompanied by Changes in Extracellular Vesicle-Associated and Plasma Fatty Acid Binding Protein 4. Obesity Surgery
  3. & Ghrelin function in human obesity and type 2 diabetes: a concise review. Obesity Reviews 18(2), 140-148.
  4. & Temporal changes in plasma markers of oxidative stress following laparoscopic sleeve gastrectomy in subjects with impaired glucose regulation. Surgery for Obesity and Related Diseases
  5. & The -765G>C Cyclooxygenase-2 Promoter Polymorphism is associated with Type 2 Diabetes Mellitus, Low High-density Lipoprotein and Manifest Angina. Journal of Diabetes & Metabolism 7(7)
  6. & Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6months following bariatric surgery. Metabolism 64(11), 1556-1563.
  7. & Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis. Journal of Diabetes Research 2015, 680867
  8. & Changes in inflammatory markers after sleeve gastrectomy in patients with impaired glucose homeostasis and type 2 diabetes. Surgery for Obesity and Related Diseases 10(6), 1123-1128.
  9. & Temporal changes in glucose homeostasis and incretin hormone response at 1 and 6 months after laparoscopic sleeve gastrectomy. Surgery for Obesity and Related Diseases 10(5), 860-869.
  10. & Changes in markers of oxidative stress and DNA damage in human visceral adipose tissue from subjects with obesity and type 2 diabetes. Diabetes Research and Clinical Practice 106(3), 627-633.
  11. et. al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. Journal of Diabetes and Its Complications 28(2), 191-195.
  12. et. al. Association of the PGC-1α rs8192678 variant with microalbuminuria in subjects with type 2 diabetes mellitus. Disease Markers
  13. et. al. New susceptibility loci associated with kidney disease in Type 1 diabetes. PLOS Genetics 8
  14. & Treatment choices for managing hyperglycaemia in patients with type 2 diabetes and moderate to severe renal disease. Diabetes Research and Clinical Practice 97(2)
  15. & Glycaemic control and other cardiovascular risk factors should be targeted independently in patients with type 2 diabetes mellitus. Atherosclerosis 217(1), 297-298.
  16. & Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk ‘Golden Years’ type 1 diabetes cohort. Diabetes Research and Clinical Practice 91(3), e71-e74.
  17. et. al. Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 94(2), 199-206.
  18. et. al. Adiponectin levels in people with Latent Autoimmune Diabetes-a case control study. BMC Research Notes 3, 317
  19. et. al. Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus. Diabetes Research and Clinical Practice 90(2), 196-201.
  20. & Relationship between proteolytic enzyme activity and oxidative stress. International Journal of Endocrinology & Metabolism 8(4), 218-219.
  21. & Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk “Golden Years” type 1 diabetes mellitus cohort. Metabolism - Clinical and Experimental 60(2), 173-179.
  22. et. al. Association between the rs1050450 glutathione peroxidase-1 (C > T) gene variant and peripheral neuropathy in two independent samples of subjects with diabetes mellitus. Nutrition, Metabolism & Cardiovascular Diseases 22(5), 417-425.
  23. & A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. British Journal of Dermatology 161(5), 1067-1071.
  24. & Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. European Heart Journal 30(10), 1263-1269.
  25. & Total antioxidant status before and after bariatric surgery for type 2 diabetes mellitus. Metabolism - Clinical and Experimental 58(9), 1366
  26. et. al. Use of a patient linked data warehouse to facilitate diabetes trial recruitment from primary care. Primary Care Diabetes 3(4), 245-248.
  27. & The adiponectin rs17300539 G>A variant and nephropathy risk. Kidney International 74(10), 1361-1361.
  28. et. al. Miochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 27(5), 945-950.

Book Chapters

  1. & Gene-Environment Interaction and Oxidative Stress in Cardiovascular Disease. In Philip Peplow, James Adams, Tim Young (Ed.), Cardiovascular and Metabolic Disease - Scientific Discoveries and New Therapies. (pp. 160-185). Cambridge: Royal Society of Chemistry.